Survey of genetic neuro-ophthalmic disorders

Ophthalmology Clinics of North America

Volumn 16, Issue 4, 2003, Pages 595-605

  Egan, Robert A ^a   Kerrison, John B ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIA; AUTOSOMAL DOMINANT OPTIC ATROPHY; CADASIL; CHROMOSOME CHIASM; CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; CONGENITAL NYSTAGMUS; DEGENERATIVE DISEASE; DUANE RETRACTION SYNDROME; EYE MOVEMENT DISORDER; GENETIC ANALYSIS; HUMAN; KIDNEY DISEASE; LACTIC ACIDOSIS; LEBER HEREDITARY OPTIC NEUROPATHY; LEIGH DISEASE; MITOCHONDRIAL ENCEPHALOPATHY; MOEBIUS SYNDROME; MUSCLE DISEASE; MYOTONIC DYSTROPHY; NEUROOPHTHALMOLOGY; NYSTAGMUS; OCULOPHARYNGEAL MUSCULAR DYSTROPHY; OPTIC DISK ANOMALY; OPTIC NERVE DISEASE; OPTIC NERVE HYPOPLASIA; PHAKOMATOSIS; PRIORITY JOURNAL; RETINITIS PIGMENTOSA; RETINOPATHY; REVIEW; SENSORY SYSTEM; STROKE; WOLFRAM SYNDROME; X CHROMOSOME LINKED DISORDER;

EID: 0346964479     PISSN: 08961549     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-1549(03)00064-6     Document Type: Review

References (133)

1. Johns DR, Smith KH, Miller NR. Leber's hereditary optic neuropathy. Clinical manifestations of the 3460 mutation. Arch Ophthalmol 1992;110:1577-81.
2. Newman NJ, Lott MT, Wallace DC. The clinical characteristics of pedigrees of Leber's hereditary optic neuropathy with the 11778 mutation. Am J Ophthalmol 1991;111:750-62.
3. Singh G, Lott MT, Wallace DC. A mitochondrial DNA mutation as a cause of Leber's hereditary optic neuropathy. N Engl J Med 1989;320:1300-5.
4. Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988;242:1427-30.
5. Johns DR, Heher KL, Miller NR, et al. Leber's hereditary optic neuropathy. Clinical manifestations of the 14484 mutation. Arch Ophthalmol 1993;111:495-8.
6. Johns DR, Neufeld MJ, Park RD. An ND-6 mitochondrial DNA mutation associated with Leber hereditary optic neuropathy. Biochem Biophys Res Commun 1992;187:1551-7.
7. Riordan-Eva P, Sanders MD, Govan GG, et al. The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain 1995;118(Pt 2):319-37.
8. Kerrison JB, Miller NR, Hsu F, et al. A case-control study of tobacco and alcohol consumption in Leber hereditary optic neuropathy. Am J Ophthalmol 2000; 130:803-12.
9. Handoko HY, Wirapati PJ, Sudoyo HA, et al. Meiotic breakpoint mapping of a proposed X linked visual loss susceptibility locus in Leber's hereditary optic neuropathy. J Med Genet 1998;35:668-71.
10. Carvalho MR, Muller B, Rotzer E, et al. Leber's hereditary optic neuroretinopathy and the X-chromosomal susceptibility factor: no linkage to DXs7. Hum Hered 1992;42:316-20.
11. Chalmers RM, Davis MD, Sweeney MG, et al. Evidence against an X-linked visual loss susceptibility locus in Leber hereditary optic neuropathy. Am J Hum Genet 1996;59:103-8.
12. Jacobi FK, Leo-Kottler B, Mittelviefhaus K, et al. Segregation patterns and heteroplasmy prevalence in Leber's hereditary optic neuropathy. Invest Ophthalmol Vis Sci 2001;42:1208-14.
13. Oostra RJ, Kemp S, Bolhuis PA, et al. No evidence for 'skewed' inactivation of the X-chromosome as cause of Leber's hereditary optic neuropathy in female carriers. Hum Genet 1996;97:500-5.
14. Sweeney MG, Davis MB, Lashwood A, et al. Evidence against an X-linked locus close to DXS7 determining visual loss susceptibility in British and Italian families with Leber hereditary optic neuropathy. Am J Hum Genet 1992;51:741-8.
15. Brown MD, Starikovskaya E, Derbeneva O, et al. The role of mtDNA background in disease expression: a new primary LHON mutation associated with Western Eurasian haplogroup. J Hum Genet 2002;110:130-8.
16. Brown MD, Sun F, Wallace DC. Clustering of Caucasian Leber hereditary optic neuropathy patients containing the 11778 or 14484 mutations on an mtDNA lineage. Am J Hum Genet 1997;60:381-7.
17. Cullom ME, Heher KL, Miller NR, et al. Leber's hereditary optic neuropathy masquerading as tobacco-alcohol amblyopia. Arch Ophthalmol 1993;111: 1482-5.
18. Newman NJ, Torroni A, Brown MD, et al. Epidemic neuropathy in Cuba not associated with mitochondrial DNA mutations found in Leber's hereditary optic neuropathy patients. Cuba Neuropathy Field Investigation Team. Am J Ophthalmol 1994;118:158-68.
19. Chalmers RM, Harding AE. A case-control study of Leber's hereditary optic neuropathy. Brain 1996; 119(Pt 5):1481-6.
20. Nikoskelainen EK, Huoponen K, Juvonen V, et al. Ophthalmologic findings in Leber hereditary optic neuropathy, with special reference to mtDNA mutations. Ophthalmology 1996;103:504-14.
21. Ortiz RG, Newman NJ, Manoukian SV, et al. Optic disk cupping and electrocardiographic abnormalities in an American pedigree with Leber's hereditary optic neuropathy. Am J Ophthalmol 1992;113:561-6.
22. Jun AS, Brown MD, Wallace CD. A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia. Proc Natl Acad Sci U S A 1994;91: 6206-10.
23. Shoffner JM, Brown MD, Stugard C, et al. Leber's hereditary optic neuropathy plus dystonia is caused by a mitochondrial DNA point mutation. Ann Neurol 1995;38:163-9.
24. Hoyt CS. Autosomal dominant optic atrophy. A spectrum of disability. Ophthalmology 1980;87:245-51.
25. Kjer B, Eiberg H, Kjer P, et al. Dominant optic atrophy mapped to chromosome 3q region. II. Clinical and epidemiological aspects. Acta Ophthalmol Scand 1996;74:3-7.
26. Eliott D, Traboulsi EI, Maumenee IH. Visual prognosis in autosomal dominant optic atrophy (Kjer type). Am J Ophthalmol 1993;115:360-7.
27. Votruba M, Fitzke FW, Holder GE, et al. Clinical features in affected individuals from 21 pedigrees with dominant optic atrophy. Arch Ophthalmol 1998;116: 351-8.
28. Bonneau D, Souied E, Gerber S, et al. No evidence of genetic heterogeneity in dominant optic atrophy. J Med Genet 1995;32:951-3.
29. Brown Jr J, Fingert JH, Taylor CM, et al. Clinical and genetic analysis of a family affected with dominant optic atrophy (OPA1). Arch Ophthalmol 1997;115: 95-9.
30. Johnston RL, Burdon MA, Spalton DJ, et al. Dominant optic atrophy, Kjer type. Linkage analysis and clinical features in a large British pedigree. Arch Ophthalmol 1997;115:100-3.
31. Jonasdottir A, Eiberg H, Kjer B, et al. Refinement of the dominant optic atrophy locus (OPA1) to a 1.4-cM interval on chromosome 3q28-3q29, within a 3-Mb YAC contig. Hum Genet 1997;99:115-20.
32. Lunkes A, Hartung U, Magarino C, et al. Refinement of the OPA1 gene locus on chromosome 3q28-q29 to a region of 2-8 cM, in one Cuban pedigree with autosomal dominant optic atrophy type Kjer. Am J Hum Genet 1995;57:968-70.
33. Seller MJ, Behnam JT, Lewis CM, et al. Linkage studies in dominant optic atrophy, Kjer type: possible evidence for heterogeneity. J Med Genet 1997;34: 967-72.
34. Kerrison JB, Arnould VJ, Ferraz Sallum JM, et al. Genetic heterogeneity of dominant optic atrophy, Kjer type: identification of a second locus on chromosome 18q12.2-12.3. Arch Ophthalmol 1999;117: 805-10.
35. Delettre C, Lenaers G, Griffoin JM, et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 2000;26:207-10.
36. Alexander C, Votruba M, Pesch UE, et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet 2000;26:211-5.
37. Satoh M, Hamamoto T, Seo N, et al. Differential sublocalization of the dynamin-related protein OPA1 isoforms in mitochondria. Biochem Biophys Res Commun 2003;300:482-93.
38. Olichon A, Emorine LJ, Descoins E, et al. The human dynamin-related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter-membrane space. FEBS Lett 2002;523(1-3):171-6.
39. Olichon A, Baricault L, Gas N, et al. Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome C release and apoptosis. J Biol Chem 2003;278:7743-6.
40. Delettre C, Griffoin JM, Kaplan J, et al. Mutation spectrum and splicing variants in the OPA1 gene. Hum Genet 2001;109:584-91.
41. Thiselton DL, Alexander C, Taanman JW, et al. A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy. Invest Ophthalmol Vis Sci 2002;43:1715-24.
42. Thiselton DL, Alexander C, Morris A, et al. A frame-shift mutation in exon 28 of the OPA1 gene explains the high prevalence of dominant optic atrophy in the Danish population: evidence for a founder effect. Hum Genet 2001;109:498-502.
43. Pesch UE, Leo-Kottler B, Mayer S, et al. OPA1 mutations in patients with autosomal dominant optic atrophy and evidence for semi-dominant inheritance. Hum Mol Genet 2001;10:1359-68.
44. Toomes C, Marchbank NJ, Mackey DA, et al. Spectrum, frequency and penetrance of OPA1 mutations in dominant optic atrophy. Hum Mol Genet 2001;10: 1369-78.
45. Delettre C, Lenaers G, Pelloquin L, et al. OPA1 (Kjer type) dominant optic atrophy: a novel mitochondrial disease. Mol Genet Metab 2002;75:97-107.
46. Marchbank NJ, Craig JE, Leek JP, et al. Deletion of the OPA1 gene in a dominant optic atrophy family: evidence that haploinsufficiency is the cause of disease. J Med Genet 2002;39:e47.
47. Al-Till M, Jarrah NS, Ajlouni KM. Ophthalmologic findings in fifteen patients with Wolfram syndrome. Eur J Ophthalmol 2002;12:84-8.
48. Strom TM, Hortnagel K, Hofmann S, et al. Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (Wolframin) coding for a predicted transmembrane protein. Hum Mol Genet 1998;7:2021-8.
49. Inoue H, Tanizawa Y, Wasson J, et al. A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat Genet 1998;20:143-8.
50. Gomez-Zaera M, Strom TM, Rodriguez B, et al. Presence of a major WFS1 mutation in Spanish Wolfram syndrome pedigrees. Mol Genet Metab 2001; 72:72-81.
51. Barrientos A, Volpini V, Casademont J, et al. A nuclear defect in the 4p16 region predisposes to multiple mitochondrial DNA deletions in families with Wolfram syndrome. J Clin Invest 1996;97:1570-6.
52. Galluzzi P, Filosomi G, Vallone IM, et al. MRI of Wolfram syndrome (DIDMOAD). Neuroradiology 1999;41:729-31.
53. Assink JJ, Tijmes NT, ten Brink JB, et al. A gene for X-linked optic atrophy is closely linked to the Xp11.4-Xp11.2 region of the X chromosome. Am J Hum Genet 1997;61:934-9.
54. Dattani MT, Martinez-Barbera JP, Thomas PQ, et al. Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet 1998;19:125-33.
55. Dattani MT, Martinez-Barbera JP, Thomas PQ, et al. HESX1: a novel gene implicated in a familial form of septo-optic dysplasia. Acta Paediatr Suppl 1999; 88:49-54.
56. Thomas PQ, Dattani MT, Brickman JM, et al. Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia. Hum Mol Genet 2001;10:39-45.
57. Parsa CF, Silva ED, Sundin OH, et al. Redefining papillorenal syndrome: an underdiagnosed cause of ocular and renal morbidity. Ophthalmology 2001; 108:738-49.
58. Parsa CF, Goldberg MF, Hunter D. Papillorenal ("renal coloboma") syndrome. Am J Ophthalmol 2002; 134:300-1.
59. Parsa CF, Goldberg MF, Hunter DG. No colobomas in "renal coloboma" syndrome. Ophthalmology 2003; 110:251-2.
60. Parsa CF, Goldberg MF, Hunter DG. Papillorenal syndrome in a Brazilian family. Arch Ophthalmol 2002; 120:1772-3.
61. Gus PI, de Souza CF, Porteous S, et al. Renal-coloboma syndrome in a Brazilian family. Arch Ophthalmol 2001;119:1563-5.
62. Sanyanusin P, McNoe LA, Sullivan MJ, et al. Mutation of PAX2 in two siblings with renal-coloboma syndrome. Hum Mol Genet 1995;4:2183-4.
63. Sanyanusin P, Norrish JH, Ward TA, et al. Genomic structure of the human PAX2 gene. Genomics 1996; 35:258-61.
64. Sanyanusin P, Schimmenti LA, McNoe LA, et al. Mutation of the PAX2 gene in a family with optic nerve colobomas, renal anomalies and vesicoureteral reflux. Nat Genet 1995;9:358-64.
65. Sanyanusin P, Schimmenti LA, McNoe TA, et al. Mutation of the gene in a family with optic nerve colobomas, renal anomolies and vesicoureteral reflux. Nat Genet 1996;13:129.
66. Schimmenti LA, Cunliffe HE, McNoe LA, et al. Further delineation of renal-coloboma syndrome in patients with extreme variability of phenotype and identical PAX2 mutations. Am J Hum Genet 1997; 60:869-78.
67. Schimmenti LA, Pierpont ME, Carpenter BL, et al. Autosomal dominant optic nerve colobomas, vesicoureteral reflux, and renal anomalies. Am J Med Genet 1995;59:204-8.
68. Spencer WH. Drusen of the optic disk and aberrant axoplasmic transport. The XXXIV Edward Jackson memorial lecture. Am J Ophthalmol 1978;85:1-12.
69. Newsome DA, Anderson RE, May JG, et al. Clinical and serum lipid findings in a large family with autosomal dominant retinitis pigmentosa. Ophthalmology 1988;95:1691-5.
70. Li Volti S, Avitabile T, Li Volti G, et al. Optic disc drusen, angioid streaks, and mottled fundus in various combinations in a Sicilian family. Graefes Arch Clin Exp Ophthalmol 2002;240:771-6.
71. Wollenhaupt M, Palmer EA, Magenis E, et al. Optic disc drusen associated with trisomy 15Q. J AAPOS 2002;6:49-50.
72. Pomeranz HD, Lessell SD. A hereditary chiasmal optic neuropathy. Arch Ophthalmol 1999;117:128-31.
73. Desmond DW, Moroney JT, Lynch T, et al. CADASIL in a North American family: clinical, pathologic, and radiologic findings. Neurology 1998;51:844-9.
74. Dichgans M, Mayer M, Uttner I, et al. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol 1998;44:731-9.
75. Robinson W, Galetta SL, McCluskey L, et al. Retinal findings in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASII). Surv Ophthalmol 2001;45:445-8.
76. Parisi V, Pierelli F, Malandrini A, et al. Visual electrophysiological responses in subjects with cerebral autosomal arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Clin Neurophysiol 2000;111:1582-8.
77. Jen J, Cohen AH, Yue Q, et al. Hereditary endotheliopathy with retinopathy, nephropathy, and stroke (HERNS). Neurology 1997;49:1322-30.
78. Laberge-le Couteulx S, Jung HH, Labauge P, et al. Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat Genet 1999;23:189-93.
79. Desnick RJ, Brady R, Barranger J, et al. Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 2003;138: 338-46.
80. Kuchle M, Brenner PM, Engelhardt A, et al. [Ocular changes in MELAS syndrome]. Klin Monatsbl Augenheilkd 1990;197:258-64.
81. Pavlakis SG, Phillips PC, DiMauro S, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 1984;16:481-8.
82. Hwang JM, Park HW, Kim SK. Optic neuropathy associated with mitochondrial tRNA[Leu(UUR)] A3243G mutation. Ophthalmic Genet 1997;18:101-5.
83. Goldenberg PC, Steiner RD, Merkens LS, et al. Remarkable improvement in adult Leigh syndrome with partial cytochrome C oxidase deficiency. Neurology 2003;60:865-8.
84. Makela-Bengs P, Suomalainen A, Majander A, et al. Correlation between the clinical symptoms and the proportion of mitochondrial DNA carrying the 8993 point mutation in the NARP syndrome. Pediatr Res 1995;37:634-9.
85. Uziel G, Moroni I, Lamantea E, et al. Mitochondrial disease associated with the T8993G mutation of the mitochondrial ATPase 6 gene: a clinical, biochemical, and molecular study in six families. J Neurol Neurosurg Psychiatry 1997;63:16-22.
86. Sacconi S, Salviati L, Sue CM, et al. Mutation screening in patients with isolated cytochrome C oxidase deficiency. Pediatr Res 2003;53:224-30.
87. Shoubridge EA. Cytochrome C oxidase deficiency. Am J Med Genet 2001;106:46-52.
88. Gamez J, Montane D, Martorell L, et al. Bilateral optic nerve atrophy in myotonic dystrophy. Am J Ophthalmol 2001;131:398-400.
89. Liquori CL, Ricker K, Moseley ML, et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001;293:864-7.
90. Brais B, Xie YG, Sanson M, et al. The oculopharyngeal muscular dystrophy locus maps to the region of the cardiac alpha and beta myosin heavy chain genes on chromosome 14q11.2-q13. Hum Mol Genet 1995; 4:429-34.
91. Brais B, Bouchard JP, Xie YG, et al. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet 1998;18:164-7.
92. Zeviani M, Moraes CT, DiMauro S, et al. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 1988;38:1339-46.
93. Moraes CT, DiMauro S, Zeviani M, et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 1989;320:1293-9.
94. Lewis S, Hutchison W, Thyagarajan D, et al. Clinical and molecular features of adPEO due to mutations in the Twinkle gene. J Neurol Sci 2002; 15(201):39-44.
95. Spelbrink JN, Li FY, Tiranti V, et al. Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet 2001;28: 223-31.
96. Kaukonen JA, Amati P, Suomalainen A, et al. An autosomal locus predisposing to multiple deletions of mtDNA on chromosome 3p. Am J Hum Genet 1996; 58:763-9.
97. Moslemi AR, Melberg A, Holme E, et al. Autosomal dominant progressive external ophthalmoplegia: distribution of multiple mitochondrial DNA deletions. Neurology 1999;53:79-84.
98. Moslemi AR, Melberg A, Holme E, et al. Clonal expansion of mitochondrial DNA with multiple deletions in autosomal dominant progressive external ophthalmoplegia. Ann Neurol 1996;40:707-13.
99. Evans JC, Frayling TM, Ellard S, Gutowski NJ. Confirmation of linkage of Duane's syndrome and refinement of the disease locus to an 8.8-cM interval on chromosome 2q31. Hum Genet 2000;106:636-8.
100. Appukuttan B, Gillanders E, Juo SH, et al. Localization of a gene for Duane retraction syndrome to chromosome 2q31. Am J Hum Genet 1999;65:1639-46.
101. Al-Baradie R, Yamada K, St. Hilaire C, et al. Duane ra- dial ray syndrome (Okihiro syndrome) maps to 20q13 and results from mutations in SALL4, a new member of the SAL family. Am J Hum Genet 2002; 71:1195-9.
102. Kohlhase J, Heinrich M, Schubert L, et al. Okihiro syndrome is caused by SALL4 mutations. Hum Mol Genet 2002;11:2979-87.
103. Engle EC, Kunkel LM, Specht LA, et al. Mapping a gene for congenital fibrosis of the extraocular muscles to the centromeric region of chromosome 12. Nat Genet 1994;7:69-73.
104. Engle EC, Marondel I, Houtman WA, et al. Congenital fibrosis of the extraocular muscles (autosomal dominant congenital external ophthalmoplegia): genetic homogeneity, linkage refinement, and physical mapping on chromosome 12. Am J Hum Genet 1995;57: 1086-94.
105. Engle EC, Goumnerov BC, McKeown CA, et al. Oculomotor nerve and muscle abnormalities in congenital fibrosis of the extraocular muscles. Ann Neurol 1997;41:314-25.
106. Wang SM, Zwaan J, Mullaney PB, et al. Congenital fibrosis of the extraocular muscles type 2, an inherited exotropic strabismus fixus, maps to distal 11q13. Am J Hum Genet 1998;63:517-25.
107. Nakano M, Yamada K, Fain J, et al. Homozygous mutations in ARIX(PHOX2A) result in congenital fibrosis of the extraocular muscles type 2. Nat Genet 2001;29:315-20.
108. Zitter F, Wiser W, Robinson A. Three-generation pedigree of a Mobius syndrome variant with chromosome translocation. Arch Neurol 1977;34:437-42.
109. Slee JJ, Smart RD, Viljoen DL. Deletion of chromosome 13 in Moebius syndrome. J Med Genet 1991;28: 413-4.
110. Kremer H, Kuyt LP, van den Helm B, et al. Localization of a gene for Möbius syndrome to chromosome 3q by linkage analysis in a Dutch family. Hum Mol Genet 1996;5:1367-71.
111. Verzijl HT, van den Helm B, Veldman B, et al. A second gene for autosomal dominant Mobius syndrome is localized to chromosome 10q, in a Dutch family. Am J Hum Genet 1999;65:752-6.
112. Jen J, Coulin CJ, Bosley TM, et al. Familial horizontal gaze palsy with progressive scoliosis maps to chromosome 11q23-25. Neurology 2002;59:432-5.
113. Stanford PM, Halliday GM, Brooks WS, et al. Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations. Brain 2000;123:880-93.
114. Brady RO, Barton NW, Grabowski GA. The role of neurogenetics in Gaucher disease. Arch Neurol 1993; 50:1212-24.
115. Loudianos G, Lovicu M, Dessi V, et al. Abnormal mRNA splicing resulting from consensus sequence splicing mutations of ATP7B. Hum Mutat 2002;20: 260-6.
116. Betz R, Rensing C, Otto E, et al. Children with ocular motor apraxia type Cogan carry deletions in the gene (NPHP1) for juvenile nephronophthisis. J Pediatr 2000;136:828-31.
117. Nettleship E. On some cases of hereditary nystagmus. Trans Ophthalmol Soc UK 1911;31:159-209.
118. Hemmes GD. Hereditary nystagmus. Am J Ophthalmol 1927;10:149-50.
119. Dudley WH. Consanguinity. A cause of congenital nystagmus. Arch Ophthalmol 1908;34:565-7.
120. Patton MA, Jeffery S, Lee N, et al. Congenital nystagmus cosegregating with a balanced 7;15 translocation. J Med Genet 1993;30:526-8.
121. Kerrison JB, Arnould VJ, Barmada MM, et al. A gene for autosomal dominant congenital nystagmus localizes to 6p12. Genomics 1996;33:523-6.
122. Ragge NK, Hartley C, Dearlove AM, et al. Familial vestibulocerebellar disorder maps to chromosome 13q31-q33: a new nystagmus locus. J Med Genet 2003;40:37-41.
123. Kerrison JB, Giorda R, Lenart TD, et al. Clinical and genetic analysis of a family with X-linked congenital nystagmus (NYS1). Ophthalmic Genet 2001;22: 241-8.
124. Kerrison JB, Vagefi MR, Barmada MM, et al. Congenital motor nystagmus linked to Xq26-q27. Am J Hum Genet 1999;64:600-7.
125. Cabot A, Rozet JM, Gerber S, et al. A gene for X-linked idiopathic congenital nystagmus (NYS1) maps to chromosome Xp11.4-p11.3. Am J Hum Genet 1999;64:1141-6.
126. Sonoda S, Isashiki Y, Tabata Y, et al. A novel PAX6 gene mutation (P118R) in a family with congenital nystagmus associated with a variant form of aniridia. Graefes Arch Clin Exp Ophthalmol 2000;238: 552-8.
127. Bassi MT, Bergen AA, Bitoun P, et al. Diverse prevalence of large deletions within the OA1 gene in ocular albinism type 1 patients from Europe and North America. Hum Genet 2001;108:51-4.
128. Durig JS, Jen JC, Demer JL. Ocular motility in genetically defined autosomal dominant cerebellar ataxia. Am J Ophthalmol 2002;133:718-21.
129. Boycott KM, Maybaum TA, Naylor MJ, et al. A summary of 20 CACNA1F mutations identified in 36 families with incomplete X-linked congenital stationary night blindness, and characterization of splice variants. Hum Genet 2001;108:91-7.
130. Pusch CM, Zeitz C, Brandau O, et al. The complete form of X-linked congenital stationary night blindness is caused by mutations in a gene encoding a leucine-rich repeat protein. Nat Genet 2000;26:324-7.
131. Yee RD, Baloh RW, Honrubia V. Eye movement abnormalities in rod monochromacy. Ophthalmology 1981;88:1010-8.
132. Arbour NC, Zlotogora J, Knowlton RG, et al. Homozygosity mapping of achromatopsia to chromosome 2 using DNA pooling. Hum Mol Genet 1997;6:689-94.
133. Kohl S, Baumann B, Broghammer M, et al. Mutations in the CNGB3 gene encoding the beta-subunit of the cone photoreceptor cGMP-gated channel are responsible for achromatopsia (ACHM3) linked to chromosome 8q21. Hum Mol Genet 2000;9:2107-16.